Does Long-Term Entecavir Treatment Really Reduce Hepatocellular Carcinoma Incidence in Patients With Hepatitis B Virus Infection? Reply

被引:1
|
作者
Hosaka, Tetsuya [1 ]
Suzuki, Fumitaka [1 ]
Kumada, Hiromitsu [1 ]
机构
[1] Toranomon Gen Hosp, Dept Hepatol, Tokyo, Japan
关键词
LAMIVUDINE;
D O I
10.1002/hep.26774
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:2053 / 2054
页数:2
相关论文
共 50 条
  • [41] Hepatitis B and C virus infection in patients with hepatocellular carcinoma
    Crespo, J
    Duenas, C
    SanchezAntolin, G
    Fabrega, E
    Carte, B
    PonsRomero, F
    MEDICINA CLINICA, 1996, 106 (07): : 241 - 245
  • [42] Do treatment really improve long-term outcome of elderly patients with hepatocellular carcinoma?
    Sinn, Dong Hyun
    Oh, Jin Myeong
    Kang, Wonseok
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 417 - 417
  • [43] Reply to: "Hepatocellular carcinoma (HCC) in the absence of cirrhosis in patients with chronic hepatitis B virus infection"
    Chayanupatkul, Maneerat
    Kanwal, Fasiha
    JOURNAL OF HEPATOLOGY, 2017, 67 (04) : 886 - 887
  • [44] Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection
    Yamada, Ryoko
    Hiramatsu, Naoki
    Oze, Tsugiko
    Morishita, Naoki
    Harada, Naoki
    Yakushijin, Takayuki
    Iio, Sadaharu
    Doi, Yoshinori
    Yamada, Akira
    Kaneko, Akira
    Hagiwara, Hideki
    Mita, Eiji
    Oshita, Masahide
    Itoh, Toshifumi
    Fukui, Hiroyuki
    Hijioka, Taizo
    Katayama, Kazuhiro
    Tamura, Shinji
    Yoshihara, Harumasa
    Imai, Yasuharu
    Kato, Michio
    Miyagi, Takuya
    Yoshida, Yuichi
    Tatsumi, Tomohide
    Kasahara, Akinori
    Hamasaki, Toshimitsu
    Hayashi, Norio
    Takehara, Tetsuo
    JOURNAL OF GASTROENTEROLOGY, 2015, 50 (07) : 785 - 794
  • [45] Is the life-long entecavir treatment really inevitable in chronic hepatitis B patients?
    Zeng, Wanjia
    Liu, Mingchen
    Peng, Siwen
    Yu, Guangxin
    Zhai, Xiangwei
    Chen, Xiangmei
    Lu, Fengmin
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (12) : 1509 - 1510
  • [46] Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infection
    Ryoko Yamada
    Naoki Hiramatsu
    Tsugiko Oze
    Naoki Morishita
    Naoki Harada
    Takayuki Yakushijin
    Sadaharu Iio
    Yoshinori Doi
    Akira Yamada
    Akira Kaneko
    Hideki Hagiwara
    Eiji Mita
    Masahide Oshita
    Toshifumi Itoh
    Hiroyuki Fukui
    Taizo Hijioka
    Kazuhiro Katayama
    Shinji Tamura
    Harumasa Yoshihara
    Yasuharu Imai
    Michio Kato
    Takuya Miyagi
    Yuichi Yoshida
    Tomohide Tatsumi
    Akinori Kasahara
    Toshimitsu Hamasaki
    Norio Hayashi
    Tetsuo Takehara
    Journal of Gastroenterology, 2015, 50 : 785 - 794
  • [47] Long-term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis B
    Chon, Young Eun
    Kim, Seung Up
    Seo, Yeon Seok
    Lee, Hye Won
    Lee, Han Ah
    Kim, Mi Na
    Roh, Yun Ho
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Tak, Won Young
    Park, Soo Young
    Kim, Beom Kyung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (01) : 200 - 207
  • [48] Long-term outcomes of entecavir monotherapy in patients with treatment-naive chronic hepatitis B
    Kim, Hyung Joon
    Lee, Hyun Woong
    Park, Ji Hoon
    Lee, Kyeong Heon
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 248 - 249
  • [49] HISTOLOGIC ASSESSMENT OF LONG-TERM ENTECAVIR (ETV) TREATMENT IN CHRONIC HEPATITIS B (CHB) PATIENTS
    Katano, Yoshiaki
    Kumada, Hiromitsu
    Kobashi, Haruhiko
    Toyoto, Joji
    Yokosuka, Osamu
    Takaguchi, Koichi
    Kage, Masayoshi
    Moriyama, Mitsuhiko
    Imozeki, Furnio
    Ishikawa, Hiroki
    Seriu, Toku
    Omota, Masao
    HEPATOLOGY, 2008, 48 (04) : 703A - 704A
  • [50] Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
    Papatheodoridis, George V.
    Dalekos, George N.
    Yurdaydin, Cihan
    Buti, Maria
    Goulis, John
    Arends, Pauline
    Sypsa, Vana
    Manolakopoulos, Spilios
    Mangia, Giampaolo
    Gatselis, Nikolaos
    Keskin, Onur
    Savvidou, Savvoula
    Hansen, Bettina E.
    Papaioannou, Christos
    Galanis, Kostantinos
    Idilman, Ramazan
    Colombo, Massimo
    Esteban, Rafael
    Janssen, Harry L. A.
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2015, 62 (02) : 363 - 370